Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
    
 
      
 

The 2019 Worldwide Asthma Guidline: A Brief Review(Recorded Webinar)


 
 
 
 
2019 Worldwide Asthma Guidelines
 
 
National asthma guidelines (Expert Report Panel 3) are now more than a decade old. More and more, clinicians are looking to the worldwide asthma guidelines to direct therapy decisions.  These worldwide guidelines, the Global Initiative for Asthma (GINA), are updated yearly. The 2019 version is novel and includes changes to what we would consider traditional therapies for treating patients with asthma. This brief update will summarize the changes and include a review of the evidence to support the modifications.  Specifically, treating patients with difficult to control asthma with newer agents (biologics) will be discussed.  By the end of the webinar, participants should have a broad understanding of the 2019 worldwide asthma guidelines.
 
 
This is a recording of a live webinar that was delivered on Tuesday, September 24 at 12:00 PM (CDT).  Step-by-step instructions to receive credit are included below. Credit for pharmacy technicians is not available.
 
For best results, please ensure you use an updated web browser with uninterrupted high-speed internet access. Speakers or headphones are required. Handouts will be downloaded as PDF documents - please ensure adobe acrobat reader is downloaded and up-to-date on your computer. This activity is best completed on a desktop or laptop computer; mobile compatibility is not guaranteed.
 
 
 
ARE YOU A STLCOP ALUM? You can participate in this activity FOR FREE! Email alumni@stlcop.edu for your coupon code!
 
 
  
 

Fee

$9.00

CE Hours

0.50

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
St. Louis College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process »  Participants are responsible for insuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
 
It is the policy of St. Louis College of Pharmacy, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
 
  

Requirements for CE Credit

INSTRUCTIONS FOR REGISTRATION AND CLAIMING CE CREDIT:
 
(1) Visit this page to register. You will be asked to log in. If you do not have an account, please create one. If you are unsure, use the password reset tool - if you do not have an account associated with that email address, you will receive an error.
Note: To better protect your privacy, this system is independent from our alumni system.
 
IMPORTANT STEP: Check your profile to be sure your NABP ePID and DOB are accurate before proceeding. If either of these fields is inaccurate, you will be unable to claim CE credit. If you need to resubmit credit, a fee may apply (see FAQ page for Late Credit/Credit Resubmission policy).
 
(2) Return to this event page. If you are not automatically redirected, click the "My account" tab above to view your current enrollments.
 
(3) Watch the video. You must be logged in with a valid account and registered in order to view. The video is embedded within the module below (click the + after you are registered and logged in). 
 
(4) Click the green test button beside the session. You must pass with at least a 70%. You may take the test as many times as needed. 
 
(5) Click the evaluation button beside the session you attended. Complete the evaluation - we value your feedback! All responses are stored anonymously.
Evaluations remain open for only until the posted expiration date of the activity, after which time evaluations will close. You will be unable to claim credit as of the posted expiration date.
 
(6) Click to submit your evaluation. As soon as you submit, a report will be automatically generated using the NABP ePID and DOB stored in your CE profile and sent to CPE Monitor. Please allow up to 48 hours to view your credit in your online NABP profile.
 
(7) If desired, you may print a statement of attendance from the "View/Print Certificate" tab above. These statements contain information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor®.


 


 

 

 

 

National asthma guidelines (Expert Report Panel 3) are now more than a decade old. More and more, clinicians are looking to the worldwide asthma guidelines to direct therapy decisions.  These worldwide guidelines, the Global Initiative for Asthma (GINA), are updated yearly. The 2019 version is novel and includes changes to what we would consider traditional therapies for treating patients with asthma. This brief update will summarize the changes and include a review of the evidence to support the modifications.  Specifically, treating patients with difficult to control asthma with newer agents (biologics) will be discussed.  By the end of the webinar, participants should have a broad understanding of the 2019 worldwide asthma guidelines.

Objectives

  • 1. Review the updated 2019 worldwide Global Initiative for Asthma (GINA) guidelines.
  • 2. Identify which patients are candidates for PRN ICS/LABA therapy.
  • 3. Briefly review available and emerging targeted therapies for severe asthma.

Speaker(s)/Author(s)

Suzanne G. Bollmeier, Pharm.D., FCCP, BCPS, AE-C
Clinical Pharmacist, South County Health Center & Professor, Pharmacy Practice, St. Louis College of Pharmacy

Activity Number

0033-0000-19-084-H01-P

Release Date: Sep 24, 2019
Credit Expiration Date: Sep 24, 2019

CE Hours

0.50

Fee

$9.00